Dr. Denis-Claude Roy
Maisonneuve Rosemount Hospital, Montreal
Maisonneuve Rosemount Hospital, Montreal
Dr. Denis-Claude Roy from the University of Montreal, Canada is our leading academic partner for the development of our blood cancer products and has collaborated with Kiadis Pharma for many years. Dr. Roy significantly contributed to the developmen... read more
Dr. Andrea Velardi
University of Perugia
University of Perugia
Dr. Velardi from University of Perugia, Italy, is one of the foremost authorities on the development of haploidentical transplantation procedures. . During the past two years, Dr. Velardi has evaluated the ability of ATIR™ and subsequently initiat... read more
In the United States Kiadis Pharma collaborates with the NIH on its lead program ATIR™:
The NIH team of Dr. Barrett, head of the transplantation unit, aims to significantly improve the outcome of bone-marrow transplantation procedures for blood canc... read more
Dr. Nelson Chao
Duke University
Duke University
Dr. Chao from Duke University, is one of the foremost authorities on the use of “mini-transplants” or “reduced conditioning regime” a new transplantation protocol that can be used in older adults to treat blood cancers. Dr. Chao is evaluating a hap... read more
